DUBLIN, Jan. 09, 2015 /PRNewswire/ --Research and Markets
(http://www.researchandmarkets.com/research/x7mdb5/global) has announced the addition of the "Global Recombinant Human Insulin Industry Report 2015" report to their offering.
The Recombinant Human Insulin industry Report 2014 is a professional and in-depth study on the current state of the Recombinant Human Insulin Industry with a focus on the Chinese situation.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Recombinant Human Insulin market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets.
Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Recombinant Human Insulin industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided.
The report focuses on the Recombinant Human Insulin industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Recombinant Human Insulin industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 126 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Key Topics Covered:
Chapter One Recombinant Human Insulin Industry Overview
Chapter Two Recombinant Human Insulin International and China Market Analysis
Chapter Three Recombinant Human Insulin Technical Data and Manufacturing Plants Analysis
Chapter Four Recombinant Human Insulin Major Countries Import Export Consumption
Chapter Five Recombinant Human Insulin Manufacturing Process and Cost Structure
Chapter Six 2009-2014 Recombinant Human Insulin Productions Supply Sales Demand Market Status and Forecast
Chapter Seven Recombinant Human Insulin Key Manufacturers Analysis
Chapter Eight Up and Down Stream Industry Analysis
Chapter Nine Recombinant Human Insulin Marketing Channels Analysis
Chapter Ten Recombinant Human Insulin Industry Development Trend
Chapter Eleven Recombinant Human Insulin Industry Development Proposals
Chapter Twelve Recombinant Human Insulin New Project Investment Feasibility Analysis
Chapter Thirteen Global and China Recombinant Human Insulin Industry Research Conclusions
- Eli Lilly
- Novo Nordisk
- United Laboratories (TUL)
For more information visit http://www.researchandmarkets.com/research/x7mdb5/global
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets